Expected valuation changes in healthcare and life sciences 2021, by subsector
For 2021, according to surveyed U.S. investment professionals, 19 percent expect valuations in the biopharmaceutical industry to increase 10 to 20 percent compared to the year before. This statistic illustrates the expected valuation changes in healthcare and life sciences in 2021, by subsector.